Dagogo Altraide is the creator and narrator behind ColdFusion, a YouTube channel with over 5 million subscribers known for deep-dive documentaries on technology, science, and business history. Born in Mumbai to Nigerian parents and raised across multiple countries before settling in Perth, Australia, Altraide built ColdFusion from a 2007 smartphone review channel into one of the internet's most respected educational documentary platforms - all while remaining largely faceless on screen. He is also a published author, music producer (under the alias Burn Water), and co-host of the Through The Web Podcast.
Matthias Wagner is the German-born co-founder and CEO of Flux, the San Francisco-based AI hardware design platform that turns text prompts into production-ready circuit boards in a single browser tab. Before Flux, he produced the Crazy Frog 'Axel F' ringtone that accumulated nearly 3.8 billion YouTube views, led product teams at Facebook for Moments, AR ads, and Oculus VR, and built digital signage company 42 media group out of a friend's garage at age 24. He founded Flux in 2019 out of frustration that hardware tooling had not evolved in decades, and by 2026 had grown the platform to over 1 million sign-ups and raised $37 million in funding led by 8VC.
Don Vaughn, Ph.D. is the Co-Founder and CEO of Ampa Health, a Palo Alto-based neurotechnology company building FDA-cleared portable TMS (transcranial magnetic stimulation) devices that compress 36 days of depression treatment into a single day. A Stanford-educated physicist turned UCLA neuroscientist, Vaughn has built a career at the intersection of brain science, machine learning, and accessibility - detoured, notably, through a DJ career that landed him a #28 iTunes Dance chart hit featuring Nick Lachey. His TEDx talk on neurohacking has surpassed one million views. Ampa raised an oversubscribed $8.5M pre-A round in October 2025, achieved FDA clearance for its Ampa One device in February 2025, and is targeting 5,000 patient remissions by end of 2026 - with a long-term audacious goal of a billion remissions in ten years.